Biogenerics at the crossroads

  title={Biogenerics at the crossroads},
  author={Carole S Ben-Maimon and Rob Garnick},
  journal={Nature Biotechnology},
Carole S. Ben-Maimon is President and CEO of Barr Pharmaceuticals, 400 Chesnut Ridge Road, Woodcliff Lake, NJ 07677, USA. e-mail: The battle for enhanced savings in prescription medicine is about to take center stage in the arena of regulatory and political debate, and the winners could be US consumers. The stakes are high. Biopharmaceutical products currently have annual sales exceeding $30 billion and several of these products, which were developed during the 1980s, have… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.

Similar Papers

Loading similar papers…